Biopharmaceutical CMC Lead

About the Job OpportunityThe Immunocore team is seeking an experienced Senior Biopharmaceutical Development Manager to lead our CMC analytical development activities from late stage to market application. As a key member of our team, you will be responsible for managing the analytical team responsible for biopharmaceutical assay development and validation,...

About the CompanyImmunocore is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines that address unmet patient needs in oncology, infectious diseases, and autoimmune disease. Our leaders in R&D are internationally recognized as some of the biotech...

Our CompanyAdaptimmune is a global biopharmaceutical company dedicated to developing cancer immunotherapies that harness the power of the body's immune system to fight cancer.About the RoleWe are seeking an experienced Clinical Operations Director to lead global clinical trial delivery, including planning, management, and reporting of trials in accordance...

This position has been deemed outside IR35 so working options of Ltd company, PAYE via CK Group or Umbrella company are all available. **Rate**: £400-£500 per day Ltd/Umbrella / £300-£375 per day PAYE As a Global Project Manager you will work in collaboration with the Asset Operation Lead (AOL) and the Asset Team (AT) members to develop, implement and...

**Who We Are** Adaptimmune is a leader in TCR T-cell therapy, focused on designing and delivering novel cancer immunotherapy products. We utilize the body’s own machinery - the T-cell - to target and destroy cancer cells. We believe our therapies have the potential to significantly impact cancer treatment and clinical outcomes. Our company culture is...

**Adaptimmune is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products for people with cancer. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors. Our company...

**Adaptimmune is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products for people with cancer. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.** **Our...